Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Actual shortage 2021-08-27 2022-08-18 144701
TEVA-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Actual shortage 2021-09-16 2024-03-18 145783
ACT REPAGLINIDE 0.5MG TABLET Actual shortage 2021-11-18 2021-11-18 149591
ACT REPAGLINIDE 1MG TABLET Actual shortage 2021-11-18 2021-11-18 149596
ACT PROGESTERONE INJECTION 50MG SOLUTION Actual shortage 2021-11-18 2022-08-18 149602
ACT REPAGLINIDE 2MG TABLET Actual shortage 2021-11-18 2021-11-18 149606
TEVA-ACYCLOVIR 800MG TABLET Actual shortage 2021-11-25 2021-11-25 149928
TEVA-SOLIFENACIN 5MG TABLET Actual shortage 2021-12-17 2024-05-23 151465
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Actual shortage 2022-05-19 2022-05-19 160980
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2022-05-19 2022-12-01 161012
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-05-16 166975
TEVA-CLOBETASOL 0.05% LOTION Actual shortage 2022-08-18 2022-08-19 167162
TEVA-PRAZOSIN 1MG TABLET Actual shortage 2022-11-14 2023-12-21 174592
TEVA-PRAZOSIN 2MG TABLET Actual shortage 2022-12-01 2023-12-21 176803
TEVA-PRAZOSIN 5MG TABLET Actual shortage 2022-12-01 2023-12-21 176806
TEVA-ZOPICLONE 5MG TABLET Actual shortage 2023-02-02 2024-02-01 183386
TEVA-DUTASTERIDE 0.5MG CAPSULE Actual shortage 2023-02-09 2024-05-23 184216
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-05-09 190785

Showing 101 to 120 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
ACT RANITIDINE 150MG TABLET Discontinued 2020-05-14 2020-05-14 115079
ACT RANITIDINE 300MG TABLET Discontinued 2020-05-14 2020-05-14 115082
TEVA-ARIPIPRAZOLE 2MG TABLET Discontinued 2020-05-14 2020-05-14 115085
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
ACT DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117

Showing 161 to 180 of 250